The modulation of STAT5A/GR complexes during fat cell differentiation and in mature adipocytes by Baugh, James E. et al.
Louisiana State University 
LSU Digital Commons 
Faculty Publications Department of Biological Sciences 
3-1-2007 
The modulation of STAT5A/GR complexes during fat cell 
differentiation and in mature adipocytes 
James E. Baugh 
Louisiana State University 
Z. Elizabeth Floyd 
Louisiana State University 
Jacqueline M. Stephens 
Louisiana State University 
Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs 
Recommended Citation 
Baugh, J., Floyd, Z., & Stephens, J. (2007). The modulation of STAT5A/GR complexes during fat cell 
differentiation and in mature adipocytes. Obesity, 15 (3), 583-590. https://doi.org/10.1038/oby.2007.500 
This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital 
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital 
Commons. For more information, please contact ir@lsu.edu. 
The Modulation of STAT5A/GR Complexes
during Fat Cell Differentiation and in Mature
Adipocytes
James E. Baugh, Jr., Z. Elizabeth Floyd, and Jacqueline M. Stephens
Abstract
BAUGH, JAMES E., JR., Z. ELIZABETH FLOYD, AND
JACQUELINE M. STEPHENS. The modulation of
STAT5A/GR complexes during fat cell differentiation and
in mature adipocytes. Obesity. 2007;15:583–590.
Objective: Signal transducer and activator of transcription
(STAT) 5A has been shown to interact with the glucocor-
ticoid receptor (GR) in adipocytes. The aim of this study
was to investigate the subcellular locations and modulation
of STAT5A/GR complexes during adipogenesis and in ma-
ture adipocytes.
Research Methods and Procedures: Both 3T3-L1 and 3T3-
F442A cells were studied by performing subcellular frac-
tionations, immunoprecipitation, and Western blotting after
various treatments.
Results: The formation of nuclear STAT5A/GR complexes
was regulated in the cytosol and in the nucleus at distinct
times during adipogenesis and in mature adipocytes.
STAT5A, but not STAT5B, forms a complex with GR in
adipocytes. The STAT5A associated with GR in the nucleus
is tyrosine phosphorylated.
Discussion: The association of STAT5A with GR in the nu-
cleus of adipocytes is modulated by the tyrosine phosphoryla-
tion of STAT5A. Both GR and STAT5A are known to have
important roles in adipocyte function. Hence, our data suggest
that the association of these two transcription factors may be
important in the regulation of adipocyte gene expression.
Key words: glucocorticoids, adipogenesis, adipocytes
Introduction
Glucocorticoid excess frequently results in obesity, insu-
lin resistance, glucose intolerance, and hypertension. Tissue
sensitivity to glucocorticoids is regulated by the expression
of glucocorticoid receptor (GR)1 and 11--hydroxysteroid
dehydrogenase type I-mediated intracellular synthesis of
active cortisol from inactive cortisone. In the GR pathway,
the receptor interacts with its steroid hormone ligand in the
cytoplasm and undergoes an allosteric change that enables
the hormone receptor complex to bind a specific DNA-
responsive element [glucocorticoid response element
(GRE)] and modulate transcription (1). Regulation of phys-
iological processes by glucocorticoids is achieved by ligand
binding to the GR and subsequent modulation of gene
expression. GR modulation of gene expression can occur by
either direct DNA binding or by protein-protein interaction
with other transcription factors, revealing the in vivo rele-
vance of GR activities that are independent of DNA binding
(2). Studies in humans have observed GR polymorphisms
associated with high blood pressure, increased visceral fat,
variations in tissue-specific steroid sensitivity, and alter-
ations in insulin sensitivity and BMI (3–6). There is evi-
dence that GR in the nervous system can affect energy
balance (7), but recent studies also suggest that central GR
and the peripheral GR in adipose tissue can contribute to
abdominal obesity (8). GR has also been shown to act as a
transcriptional coactivator of signal transducer and activator
of transcription (STAT) 5 and can enhance STAT5-depen-
dent transcription (9).
STAT5 proteins were originally recognized as mammary
gland factor, a protein from mouse mammary gland that
bound to the -casein promoter (10). It was subsequently
determined that mammary gland factor was two closely
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related proteins, STAT5A and STAT5B (11), which are
expressed in all tissues (12). Transgenic deletion studies
indicate that a major function of STAT5 proteins is in the
regulation of mammary tissue development (13), but nu-
merous lines of evidence suggest a role for STAT5 proteins
in the modulation of adipocyte function. During differenti-
ation of 3T3-L1 adipocytes, expression levels of STAT5A
and 5B have been shown to be highly induced (14). Fur-
thermore, growth hormone (GH)-dependent adipogenesis of
3T3-F442A cells has been shown to be attenuated by
STAT5 antisense oligonucleotides (15), and constitutively
active STAT5 can replace the requirement for GH in adi-
pogenesis of these cells (16). Moreover, ectopic expression
of STAT5A has been shown to confer adipogenesis in two
different non-precursor cell lines (17). Transgenic deletion
of STAT5A, STAT5B, or both STAT5 genes in mice resulted
in a significant reduction in fat pad size compared with
wild-type mice (13). In rat primary preadipocytes, GH treat-
ment has been shown to result in STAT5-mediated inhibi-
tion of acid-binding protein 2 expression (18). In summary,
both in vitro and in vivo studies indicate that STAT5 pro-
teins have an important role in adipogenesis and fat cell
function.
Because both STAT5A and GR have important roles in
adipocytes, we have examined the association of these
two transcription factors during adipogenesis and in ma-
ture fat cells. Our results reveal that the differentiation-
dependent increase in the STAT5A/GR interaction is due
to an increased association of these proteins in the cy-
tosol. However, we also observed that these two tran-
scription factors associate in the nucleus immediately
after the induction of differentiation and when STAT5A
proteins are tyrosine phosphorylated. We did not observe
an association of STAT5B with GR under any conditions
that we examined. In summary, all of our studies reveal
that the increased association of STAT5A with GR in the
nucleus of fat cells tightly correlates with activation of
STAT5A and indicates that GR likely functions to mod-
ulate STAT5A-mediated transcription because the major-
ity of nuclear STAT5A proteins are associated with GR.
Hence, the association of GR and STAT5A not only plays
a role in the modulation of transcription by STAT5 but
also may play a role in the contribution of GR to the
metabolic syndrome.
Research Methods and Procedures
Materials
Dulbecco’s modified Eagle’s medium (DMEM) was pur-
chased from Sigma (St. Louis, MO). Fetal bovine serum
(FBS) was purchased from Atlanta Biologicals (Atlanta,
GA). Calf serum was purchased from BioSource Interna-
tional (Camarillo, CA). Polyclonal phosphospecific STAT5
(Y694) antibody and antirabbit STAT5B were purchased
from Upstate Biotechnology (Lake Placid, NY). STAT5A
polyclonal antibody was purchased from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA). GH, prolactin (PRL),
and dexamethasone were purchased from Sigma.
Cell Culture
Murine 3T3-L1 preadipocytes were plated and grown to
2 days post-confluence in DMEM containing 10% bovine
serum. Medium was changed every 48 hours. Cells were
induced to differentiate by changing the medium to DMEM
containing 10% FBS, 0.5 mM 3-isobutyl-methylxanthine, 1
M dexamethasone, and 1.7 M insulin. After 48 hours,
this medium was replaced with DMEM supplemented with
10% FBS, and the cells were maintained in this medium
until utilized for experimentation.
Preparation of Whole-Cell Extracts
Cell monolayers were rinsed with phosphate-buffered
saline and then harvested in a non-denaturing buffer con-
taining 10 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EGTA,
1 mM EDTA, 1% Triton X-100, 0.5% Nonidet P-40, 1 M
phenylmethylsulfonyl fluoride, 1 M pepstatin, 50 trypsin-
inhibitory mU of aprotinin, 10 M leupeptin, and 2 mM
sodium vanadate. Samples were extracted for 30 minutes on
ice and centrifuged at 15,000 rpm at 4 °C for 15 minutes.
Supernatants containing whole-cell extracts were analyzed
for protein content by bicinchoninic acid analysis (Pierce
Chemical, Rockford, IL) according to the manufacturer’s
instructions.
Preparation of Nuclear and Cytosolic Extracts
Cell monolayers were rinsed with phosphate buffer solu-
tion and then harvested in a nuclear homogenization buffer
(NHB) containing 20 mM Tris (pH 7.4), 10 mM NaCl, 3
mM MgCl2, 5 M dithiothreitol, 1 M phenylmethylsulfo-
nyl fluoride, 1 M pepstatin, 50 trypsin-inhibitory mU of
aprotinin, 10 M leupeptin, and 2 mM sodium vanadate.
Igepal CA-630 (Nonidet P-40) was added to a final concen-
tration of 0.15%, and cells were homogenized with 16
strokes in a Dounce homogenizer. The homogenates were
centrifuged at 3500 rpm for 5 minutes. Supernatants were
saved as cytosolic extract, and the nuclear pellets were
resuspended in 0.5 volumes of NHB and were centrifuged
as before. The pellet of intact nuclei was resuspended again
in one-half of the original volume of NHB and centrifuged
again. The majority of the pellet (intact nuclei) was resus-
pended in an extraction buffer containing 20 mM HEPES
(pH 7.9), 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 5
M dithiothreitol, 1 M phenylmethylsulfonyl fluoride, 1
M pepstatin, 50 trypsin-inhibitory mU of aprotinin, 10 M
leupeptin, 2 mM sodium vanadate, and 25% glycerol. Nu-
clei were extracted for 30 minutes on ice. The samples were
subjected to centrifugation at 10,000 rpm at 4 °C for 10
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minutes. Supernatants containing nuclear extracts were an-
alyzed for protein content, using a bicinchoninic acid pro-
tein assay kit (Pierce).
Immunoprecipitations (IPs) of GR from Adipocyte
Extracts
Cells were harvested under non-denaturing conditions,
and the protein content of the whole-cell extracts was ana-
lyzed as described above. After a single freeze-thaw cycle,
the protein extracts were preincubated with protein A aga-
rose, and the resulting supernatant was then incubated with
5 g of the polyclonal anti-GR antibody for 1 hour at 4 °C.
Protein-A agarose (Repligen Corporation, Waltham, MA)
was added to the mixture, and the sample was rotated for an
additional hour. Bound GR and any associated proteins
were isolated by pelleting this mixture. The pellets were
rinsed twice with phosphate-buffered saline, and bound
proteins were eluted from the agarose by incubation at
100 °C for 10 minutes after the addition of Laemmli sample
buffer. These samples were separated by sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis and ana-
lyzed by Western blotting with either STAT5A or GR
antibodies.
Gel Electrophoresis and Immunoblotting
Proteins were separated in 7.5% polyacrylamide (Na-
tional Diagnostics, Atlanta, GA) gels containing SDS ac-
cording to Laemmli (19) and transferred to nitrocellulose
(Bio-Rad, Hercules, CA) in 25 mM Tris, 192 mM glycine,
and 20% methanol. After transfer, the membrane was
blocked in 4% milk overnight at 4 °C. Results were visual-
ized with horseradish peroxidase-conjugated secondary an-
tibodies (Jackson ImmunoResearch Laboratories Inc., West
Grove, PA) and enhanced chemiluminescence (Pierce).
Results
We first examined the subcellular location of the
STAT5A/GR interaction during adipocyte differentiation in
the 3T3-L1 cells. An analysis of whole-cell and cytosolic
extracts during the first 3 days of differentiation confirmed
that the expression of STAT5A and STAT5B was induced
during adipogenesis and that STAT5 proteins are tyrosine
phosphorylated very early during adipocyte differentiation
(Figure 1). In addition, STAT5 activation preceded the
induction of STAT5 expression that occurred later in adi-
pocyte differentiation. At the 72-hour time-point, we also
included an acute exposure to GH. STAT5 was also potently
activated by acute GH treatment. These extracts were also
used for cell fractionation procedures to obtain cytosolic
and nuclear extracts. The association of the STAT5A and
GR was examined in these studies by immunoprecipitating
cytosolic and nuclear extracts with an antibody directed
against GR and using these precipitates to look for the
presence of STAT5A. As shown in Figure 1B, we did not
observe the presence of the STAT5A/GR complex in cyto-
solic samples until 3 days (72 hours) after the induction of
differentiation. Our previous work on whole-cell extracts
indicated a similar regulation in the association of STAT5A
with GR receptor in 3T3-L1 cells (17). However, the
STAT5A/GR complex was detected in the nucleus imme-
diately after the induction of differentiation and also in Day
3 adipocytes that were exposed to GH treatment. Also, the
presence of STAT5A/GR complex in the nucleus correlated
with the tyrosine phosphorylation of STAT5. The majority
of GR is found in the nucleus, and GR expression was not
substantially regulated during adipogenesis.
These studies suggested that GR associates with active, or
tyrosine phosphorylated, STAT5A proteins in the nucleus.
To determine whether STAT5A proteins associated with
GR were tyrosine phosphorylated, we performed IPs with
GR in GH-treated or -untreated cells and immunoblotted
with STAT5A or STAT5pY. As shown in Figure 2, left, we
Figure 1: STAT5A/GR complexes are present in the nucleus
immediately after the induction of differentiation and in differen-
tiating preadipocytes exposed to GH in 3T3-L1 cells. (A) Whole-
cell extracts were isolated at the indicated times after initiation of
differentiation or at 72 hours after the initiation of differentiation
after an acute treatment with 40 nM GH. One hundred micrograms
of each extract was separated by SDS-polyacrylamide gel electro-
phoresis, transferred to nitrocellulose, and subjected to Western
blot analysis. The detection system was horseradish peroxidase-
conjugated secondary antibodies and enhanced chemilumines-
cence. (B) Cytosolic and nuclear extracts were isolated at the
various times indicated. These extracts were used for Western blot
analysis or IP using anti-GR antibody to examine STAT5A/GR
complexes. This was a representative experiment independently
performed three times.
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observed an increase in the association of STAT5A and GR
in the nucleus after acute GH treatment. The cytosolic levels
of the complex were unaffected. In addition, we were able
to observe that GR associates with phosphorylated STAT5A
proteins (Figure 2, right), but only in the nucleus. We
performed the IPs with buffer alone (mock) to further indi-
cate the specificity of the gel bands we observed. An anal-
ysis of the supernatants from these IPs indicated that
STAT5A was present (Figure 3, bottom), indicating that not
all of the STAT5A in the nucleus is associated with GR. In
addition, proteins coimmunoprecipitating with GR were not
observed in the absence of primary antibody (data not shown).
Because GH treatment induced the association of
STAT5A and GR proteins in the nucleus of differentiating
3T3-L1 cells, we examined this interaction in mature, fully
differentiated 3T3-L1 adipocytes. As shown in Figure 3,
acute GH treatment resulted in the nuclear translocation of
STAT5A but did not affect the subcellular distribution of
GR. The amount of STAT5A/GR complexes detected in the
cytosol was unaffected by GH. A similar analysis with
STAT5B did not reveal an association of these two proteins
in the cytosol or nucleus, despite nuclear translocation of
STAT5B.
To further examine the specificity of the interaction be-
tween STAT5A/GR, we repeated these studies in another
adipocyte cell culture model, the 3T3-F442A cell line. We
observed the interaction of these two transcription factors
by immunoprecipitating with GR and immunoblotting with
STAT5A, as we had previously performed in the 3T3-L1
cells (Figures 1 to 3). However, we also observed the
STAT5A/GR complex by immunoprecipitating with
STAT5A and immunoblotting with GR. As shown in Figure
4, the STAT5A/GR cytosolic complex was not regulated by
GH or PRL treatment. However, the activation of STAT5A
after either GH or PRL treatment resulted in a substantial
association of these two transcription factors in the nucleus
of 3T3-F442A adipocytes. Western blot analysis confirmed
that that GH or PRL treatment did not affect the amount of
GR in the nucleus but did result in STAT5 tyrosine phos-
phorylation (data not shown).
Discussion
The novel observations in this study demonstrate that the
previously observed increased association of STAT5A with
GR that occurs during adipocyte differentiation is largely
due to the interaction of these transcription factors in the
cytosol (Figure 1B). We have observed that this cytosolic
complex is not regulated by various effectors of adipocyte
metabolism, including tumor necrosis factor  and agonists
or antagonists of GR (data not shown). However, the acti-
vation of STAT5 by GH or PRL resulted in a large increase
in the amount of GR-associated STAT5A proteins in the
nucleus (Figures 1 to 4). In fact, all of our results indicate
Figure 2: Tyrosine phosphorylated STAT5A proteins are present in the nuclear STAT5A/GR complexes induced by GH treatment.
Cytosolic and nuclear extracts were isolated from fully differentiated 3T3-L1 adipocytes that were harvested after an acute 15-minute
treatment with 40 nM GH. Each extract was subjected to IP with GR and Western blotting analysis with antibodies directed against STAT5A
(A) or phospho-STAT5 Tyr694 (B). Three hundred micrograms of total protein was used for IP, and 15 g of protein was used for Western
blotting. Some IPs contained buffer, but not extract, and are labeled as Mock. This was a representative experiment independently performed
three times.
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that the presence of STAT5A/GR complexes in the nucleus
strongly correlates with the activation of STAT5A proteins.
Moreover, we observed that this correlation exists under a
variety of different conditions. We observed the nuclear
association of these two transcription factors immediately
after the initiation of differentiation and in differentiating
3T3-L1 cells at 72 hours after GH stimulation (Figure 1B).
We have also observed the induction of STAT5A/GR com-
plexes in mature adipocytes after acute GH or PRL treat-
ment (Figures 3 and 4). Acute treatments with either an
agonist or antagonist of GR activity, which do not affect
STAT5 activity, had no effect on the levels of STAT5A/GR
complexes in the nucleus (data not shown).
All of our observations suggest that the association of
STAT5 proteins with GR in the nucleus correlates with
activation of STAT5A. We have tested this hypothesis by
using a STAT5 phosphospecific antibody for Western blot-
ting after IP of GR from nuclear extracts. The results in
Figure 2 demonstrate an interaction of GR with phosphor-
ylated STAT5 proteins in the nucleus after GH treatment.
This observation confirms a significant amount of data
obtained under various conditions that demonstrate a tight
correlation between STAT5A tyrosine phosphorylation and
the association of STAT5A with GR in the nucleus (Figures
2 to 4) of both 3T3-L1 and 3T3-F442A adipocytes. How-
ever, we cannot conclusively demonstrate that all of the
STAT5A present in the STAT5A/GR nuclear complexes is
tyrosine phosphorylated, and the role of the STAT5A phos-
phorylation in this interaction has not been conclusively
demonstrated. We have also observed that not all of the
STAT5A present in the nucleus is associated with GR
(Figure 3, bottom).
The association of GR with STAT5 was described nearly
10 years ago when it was shown that GR could act as a
transcriptional coactivator for STAT5 by enhancing
STAT5-dependent transcription (9). These studies also re-
vealed that the STAT5/GR complex bound to DNA inde-
pendently of the GRE and diminished the glucocorticoid
response of a GRE-containing promoter. Additional studies
of STAT5 and GR revealed that these two transcription
factors cooperate in the induction of transcription of the
-casein gene (9). In addition, it was shown that transcrip-
tional cooperation of GR and STAT5 was independent of
the ligand-binding domain of GR (9). Interestingly, it has
been observed that DNA binding-defective GR is still able
to interact with phosphorylated STAT5 proteins (2). How-
ever, other studies have suggested that binding sites for both
STAT5 and GR are a prerequisite for the synergism of these
two transcription factors on the regulation of the -casein
gene by PRL and glucocorticoids (20). We hypothesize that
the nuclear STAT5A/GR complex is likely an important
mediator of transcription for specific adipocyte genes. How-
ever, the possible function of this complex is the cytosol is
not clear.
Although our studies only revealed a physical association
of STAT5A, but not STAT5B, with GR in cultured adipo-
cytes; similar experiments in mammary cells have shown
that STAT5A and STAT5B can physically associate with
GR (21). Also, in mammary cells, the association was not
dependent on hormone treatment and was evident at all
Figure 3: GH induces the formation of nuclear STAT5A/GR
complexes in fully differentiated 3T3-L1 adipocytes. Whole-cell,
cytosolic, and nuclear extracts were isolated from mature 3T3-L1
adipocytes in the absence or presence of a 15-minute GH treatment
(40 nM). The extracts were used for Western blotting or for IP to
examine STAT5A/GR complexes. The supernatants (SUPE) from
the IPs were concentrated and used for Western blot analysis. This
was a representative experiment independently performed three
times.
Figure 4: The modulation of STAT5A/GR complexes in 3T3-
F442A adipocytes. Cytosolic and nuclear extracts were isolated
from fully differentiated 3T3-F442A adipocytes that were un-
treated or exposed to 40 nM GH or 21 nM PRL for 20 minutes.
The extracts were immunoprecipitated with a polyclonal anti-GR
(bottom) or polyclonal anti-STAT5A (top) followed by Western
blot analysis as indicated to examine the STAT5A/GR complexes.
This was a representative experiment independently performed
three times.
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stages of mammary gland development (21). A direct inter-
action between liganded GR and STAT5 has been observed
in CTLL-2 cells in a STAT5 phosphorylation-independent
manner (22). Also, other studies suggest that STAT5 phos-
phorylation does not significantly influence GR-STAT5 in-
teraction (23). Overall, these studies in CTLL-2 cells and in
mammary cells are highly distinct from what we observed
in cultured fat cells. In adipocytes, the association of
STAT5A and GR was increased during adipogenesis, and
the nuclear association of the proteins was tightly correlated
with STAT5 phosphorylation. However, we were unable to
detect an association of STAT5B with GR (Figure 3, panel
4). Nonetheless, we cannot rule out that an interaction of
GR and STAT5B may occur in adipocytes.
We have reported other differences between STAT5A
and STAT5B in 3T3-L1 cells in studies where we demon-
strated that STAT5A, but not STAT5B, can confer adipo-
genesis in non-precursor cells (17). Hence, we hypothesize
that the adipogenic properties of STAT5A may be affected
by its ability to associate with GR in the early stages of
adipogenesis. Nonetheless, recent studies reveal that the
cooperativity of STAT5A with GR is very complex, and the
mode of action of GR depends not only on the type of the
particular promoter at which it acts but also in the concen-
tration of the GR (24). In all of our experiments, we ob-
served that the nuclear association of STAT5A and GR in
adipocytes correlates with the activation of STAT5A pro-
teins but was unaffected by effectors of GR. Therefore, our
results support previous studies that indicate that the phys-
ical association between GR and STAT5 functions to en-
hance STAT5-dependent transcription.
Immunofluorescence microscopy studies have been used
to demonstrate that PRL-activated STAT5 can translocate
GR into the nucleus and that ligand-bound GR can translo-
cate STAT5 into the nucleus (25). We have not observed
similar findings in fat cells. We predict that our observed
differences in adipocytes occur for at least two reasons.
First, the majority of GR in adipocytes is already present in
the nucleus. Second, PRL or GH exposure of adipocytes
results in the tyrosine phosphorylation and nuclear translo-
cation of STAT5A but does not affect levels of GR in the
cytosol or the nucleus. Hence, our results suggest that
phosphorylated STAT5A proteins do not associate with GR
until STAT5A has translocated to the nucleus.
It has been shown that the enhancement of STAT5 DNA
binding by GR results in the formation of a complex that
exhibits prolonged DNA binding after PRL treatment and
that correlates with increased STAT5 tyrosine phosphory-
lation (25). Our results also suggest that the ability of GR to
affect STAT5A is modulated by STAT5A phosphorylation.
In fact, all of our analyses demonstrate a correlation be-
tween STAT5A activation and the association of STAT5A
with GR in the nucleus (Figures 1 to 4). These observations
are supported by a hypothesis in another study that suggests
that the GR-enhanced STAT5 DNA binding could be mod-
ulating the rate of STAT5 dephosphorylation (25). Under
these circumstances, we predict that GR associated with
STAT5A could physically prevent access of a phosphatase
to STAT5 and enhance its activation.
Although we have not identified a function for the adi-
pocyte STAT5A/GR complex, our results support the hy-
pothesis that GR affects the ability of STAT5A to modulate
transcription. Interestingly, the phenotype of STAT5A- or
STAT5B-deficient mice (8,26) is very similar to the recently
described petite stature of hepatic GR-deficient mice (23).
Figure 5: Models for the cytosolic and nuclear interaction of
STAT5A and GR. (A) The nuclear association of STAT5A and
GR correlates with the tyrosine phosphorylation of STAT5 ob-
served shortly after the induction of differentiation. Cytosolic
STAT5A/GR complexes are observed in the cytosol at 72 hours
after the induction of differentiation. The presence of these com-
plexes coincides with the induction in STAT5 expression that is
observed. (B) The Venn diagrams represent two primary observa-
tions in our studies. The circles indicate that the activation of
STAT5A does not affect the amount of STAT5A/GR complexes
present in the cytosol. In addition, these circles indicate that the
majority of STAT5A proteins in the nucleus are associated with GR.
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These studies have revealed that GR function in hepatocytes
is essential to promote postnatal body growth. The growth-
promoting activity of GR is not mediated by its binding to
GREs but rather through its ability to act as a coactivator by
synergizing with STAT5 (23).
Our studies on the modulation of STAT5A/GR com-
plexes in 3T3-L1 cells suggest that the activation of STAT5
is responsible for the formation of nuclear STAT5A/GR
complexes. These results are summarized in Figure 5A, and
a model of the subcellular distribution of these complexes is
represented in Figure 5B. Clearly, our results indicate that
the induction of nuclear STAT5A/GR complexes during
adipogenesis correlates with the tyrosine phosphorylation of
STAT5A, and a large portion of nuclear STAT5A is asso-
ciated with GR. In addition, activators of STAT5A, such as
GH, do not affect the amount of GR-associated STAT5A
proteins in the cytosol but do result in a substantial increase
in the association of these two transcription factors in
the nucleus. The function of the STAT5A/GR complex in
the cytosol is unclear, yet our results strongly suggest that
the role of the highly regulated STAT5A/GR complex in the
nucleus is to modulate the ability of STAT5 to regulate
transcription. We are currently performing experiments to
identify a function(s) of the nuclear STAT5A/GR complex.
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